Glioblastoma
The most common length of survival following diagnosis is 12 to 15 months, with fewer than 3% to 5% of people surviving longer than five years. Without treatment survival is typically 3 months.
University of Miami Division of Surgical Neurooncology
The past chair of the department was Dr. Barth A. Green, founder of Project Medishare for Haiti, and co-chairman Dr. Roberto C. Heros. The current chair is Dr. Alan Levi.New clinical trial is being explored at select and distinguished medical centers including Johns Hopkins Hospital, Columbia University Medical Center, University of California San Francisco, University of Miami and a few others. This treatment is tailored to newly diagnosed patients with glioblastoma multiforme, and aims to activate the patients's immune system against the tumor antigen to prevent recurrence using HSPPC-96. Preliminary data suggests that this novel agent has promising results against cancer. UM is the only center conducting this trial in the state of Florida.Glioma treatment depends on the clinical and pathological presentation of the tumor. Treatment involves a combined approach that may utilize surgery, radiation and chemotherapy.